Chengyong Du

miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells

Danni Chen, Wengong Si, Jiaying Shen et al. · Cell Death and Disease · 2018 · 168 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer

Weiyang Lou, Bisha Ding, Guansheng Zhong et al. · Aging · 2019 · 104 citations · Full text

Medicine, Molecular Genetics, Oncology +17

A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance

Wengong Si, Jiaying Shen, Chengyong Du et al. · Cell Death and Differentiation · 2017 · 93 citations · Full text

Medicine, Cancer Biology, Oncology +17

Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer

Jiaying Shen, Jie Pan, Chengyong Du et al. · Cell Death and Disease · 2017 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +15

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer

Peifen Fu, Minya Yao, Yu Liu et al. · OncoTargets and Therapy · 2014 · 82 citations · Full text

Medicine, Oncology, Breast Oncology +14